YOLFTbeta
Pulike Biological Engineering

Pulike Biological Engineering

603566 · SHG · Healthcare / Biotechnology

9.14CNY-0.02 (-0.22%)

Price History

Full chart

Market Stats

Previous Close9.16
Open9.15
Day Range9.07 – 9.27
52-Week Range9.56 – 14.58
Volume2.78M
Market Cap3.54B
P/E (TTM)23.81
Forward P/E0.00
EPS0.43
Dividend Yield5.86%
Beta0.30
50-Day Avg10.34
200-Day Avg11.76

About

Pulike Biological Engineering, Inc. engages in the research, development, production, and sale of veterinary biological products, chemical drugs, and traditional Chinese veterinary drugs. The company offers vaccines, antibodies, and medicines for livestock, poultry, and pets. Pulike Biological Engineering, Inc. was founded in 1995 and is headquartered in Luoyang, China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Wei Hu
  • Employees1.52K
  • HeadquartersNo.15 Zhenghe Road, Luoyang, China, 471000, China
  • Websitehttps://www.pulike.com.cn

Leadership

  • Mr. Wei HuMD & Director · b. 1973
  • Ms. Lian Feng PeiCFO & Director · b. 1973
  • Mr. Rui ZhaoSecretary of the Board & Director · b. 1984
  • Dr. Ke Gong Tian Ph.D.Deputy General Manager · b. 1964
  • Ms. Bing HanDeputy General Manager · b. 1981
  • Fang Yuan ChenAccounting Supervisor

Financials

Income Statement

Currency: CNY2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue266.43M292.35M412.62M417.53M472.08M475.69M478.14M583.10M529.90M608.06M663.19M928.51M1.10B1.23B1.25B1.04B1.09B
Growth (%)-+9.73%+41.14%+1.19%+13.07%+0.76%+0.51%+21.95%-9.12%+14.75%+9.07%+40.01%+18.31%+11.97%+1.84%-16.77%+4.54%
Cost of Revenue73.73M83.82M127.11M121.30M125.84M119.79M130.40M167.70M167.95M200.23M257.64M331.23M379.95M459.74M488.40M405.63M437.35M
Gross Profit192.71M208.54M285.52M296.23M346.24M355.90M347.73M415.40M361.95M407.83M405.56M597.28M718.62M770.33M764.30M636.93M652.53M
Gross Margin72.33%71.33%69.20%70.95%73.34%74.82%72.73%71.24%68.31%67.07%61.15%64.33%65.41%62.63%61.01%61.09%59.87%
Operating Expense83.62M115.59M153.15M151.06M177.20M198.30M193.43M232.33M254.06M271.09M298.67M380.73M434.03M593.41M571.28M539.14M462.38M
Operating Income109.09M92.95M132.36M145.17M169.04M157.61M154.30M183.07M107.89M136.74M106.88M216.55M284.58M176.92M193.01M97.79M190.14M
Operating Margin40.94%31.79%32.08%34.77%35.81%33.13%32.27%31.40%20.36%22.49%16.12%23.32%25.91%14.38%15.41%9.38%17.45%
EBITDA112.99M97.25M137.11M167.03M208.10M199.50M205.35M258.74M174.40M195.50M168.11M312.81M343.71M252.74M287.55M218.29M329.88M
EBITDA Margin42.41%33.26%33.23%40.00%44.08%41.94%42.95%44.37%32.91%32.15%25.35%33.69%31.29%20.55%22.95%20.94%30.27%
Net Income92.76M83.99M115.38M129.21M162.86M140.26M141.74M188.00M114.19M135.61M109.25M216.66M244.14M167.82M174.52M92.81M184.99M
Net Income Margin34.82%28.73%27.96%30.95%34.50%29.48%29.64%32.24%21.55%22.30%16.47%23.33%22.22%13.64%13.93%8.90%16.97%
R&D---26.03M32.79M36.87M41.76M58.46M61.21M73.46M90.82M114.84M82.93M92.62M101.10M113.25M99.65M
R&D as % of Total Revenue---6.23%6.95%7.75%8.73%10.03%11.55%12.08%13.69%12.37%7.55%7.53%8.07%10.86%9.14%
Interest Expense1.53M868.40K5.14M3.95M202.20K1.46M50.53K59.26K54.69K442.63K615.52K75.15K226.06K1.08M1.12M264.92K59.75K
Interest Expense % of Total Revenue0.57%0.30%1.25%0.95%0.04%0.31%0.01%0.01%0.01%0.07%0.09%0.01%0.02%0.09%0.09%0.03%0.01%

Balance Sheet

Currency: CNY2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets326.26M441.53M500.56M582.13M730.68M837.72M1.50B1.74B1.81B1.90B1.91B2.03B2.17B3.39B3.26B3.10B3.24B
Total Liabilities77.19M245.65M189.31M141.66M127.35M154.14M166.49M255.91M236.27M267.51M247.42M319.16M367.83M588.07M538.33M471.11M500.00M
Total Equity249.06M195.88M311.26M440.47M603.33M683.59M1.34B1.48B1.57B1.64B1.66B1.71B1.80B2.80B2.72B2.63B2.61B
Cash104.20M137.45M160.70M157.52M168.34M213.53M391.18M428.63M263.48M451.36M296.11M253.65M168.83M281.04M317.21M205.26M137.31M
Total Debt-32.00M113.00M50.00M---45.74M27.00M12.71M---9.69M1.06M20.23M-
Net Debt-104.20M-105.45M-47.70M-107.52M-168.34M-213.53M-391.18M-382.89M-236.49M-438.66M-296.11M-253.65M-168.83M-273.80M-315.16M-205.08M-

Cash Flow

Currency: CNY2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-70.98M152.54M147.96M181.21M151.21M187.09M253.03M140.86M126.27M140.10M261.83M212.53M228.36M282.78M268.79M356.34M
Investing Cash Flow-21.80M-51.85M-62.53M-84.15M-120.16M-64.36M-525.59M-207.99M-240.52M140.41M-184.42M-107.74M-130.51M-956.29M-1.66M-188.26M-
Financing Cash Flow-52.55M13.37M-66.77M-67.00M-50.23M-60.00M518.07M-4.18M-64.57M-78.98M-110.65M-196.73M-157.57M829.07M-241.03M-191.56M-
Capital Expenditure25.80M47.80M63.73M86.20M114.19M64.47M127.84M73.79M59.29M53.62M85.18M177.14M317.54M356.76M304.98M121.06M75.04M
Free Cash Flow-25.80M23.18M88.81M61.76M67.02M86.74M59.25M179.24M81.58M72.65M54.93M84.69M-105.01M-123.63M-22.20M147.73M281.30M
Dividends Paid37.05M80.48M147.77M4.00M227.60K60.00M48.00M48.00M64.27M64.67M96.02M63.18M157.32M63.65M225.00M137.85M205.15M
FCF to OCF-32.66%58.22%41.74%36.98%57.36%31.67%70.84%57.91%57.54%39.20%32.35%-49.41%-54.14%-7.85%54.96%78.94%
Dividend Paid to FCF-143.57%347.17%166.38%6.47%0.34%69.17%81.02%26.78%78.78%89.02%174.81%74.60%-149.82%-51.48%-1013.36%93.31%72.93%

Earnings

Report DateOct 23, 2015Mar 2, 2016Apr 29, 2016Aug 18, 2016Oct 28, 2016Apr 28, 2017Aug 17, 2017Oct 17, 2017Feb 28, 2018Apr 28, 2018Aug 10, 2018Oct 26, 2018Mar 29, 2019Apr 30, 2019Aug 21, 2019Oct 25, 2019Mar 28, 2020Apr 28, 2020Aug 28, 2020Oct 28, 2020Apr 30, 2021Jul 29, 2021Oct 28, 2021Apr 28, 2022Aug 9, 2022Oct 25, 2022Apr 25, 2023
EPS Estimate---------------------------
EPS Actual0.150.080.140.150.210.100.090.100.070.120.120.130.050.040.160.090.040.040.200.130.280.240.210.040.140.170.12
Surprise---------------------------
TimingAfter-hours-Pre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-market-Pre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hours-After-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap3.54B
Enterprise Value2.83B
Trailing P/E23.81
Forward P/E0.00
Price / Sales3.47
Price / Book1.39
EPS0.43
Book Value7.45
Revenue (TTM)1.02B
Gross Profit (TTM)591.29M
EBITDA239.51M
Profit Margin14.30%
Operating Margin8.19%
Return on Equity5.04%
Return on Assets2.10%
Shares Outstanding346.06M
Shares Float206.54M
Beta0.30
Dividend Yield5.86%
Dividend Rate0.60
Payout Ratio139.53%

Dividends

20231×
0.35Jun 20, 2023
20221×
0.20Jun 20, 2022
20211×
0.50Jun 17, 2021
20201×
0.20Jun 17, 2020
20191×
0.30May 28, 2019
20181×
0.20Jun 5, 2018
20171×
0.20Jun 5, 2017
20161×
0.30May 31, 2016

Stock Splits

  • May 31, 20162:1